These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 7666497
1. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. Schirmbeck R, Böhm W, Ando K, Chisari FV, Reimann J. J Virol; 1995 Oct; 69(10):5929-34. PubMed ID: 7666497 [Abstract] [Full Text] [Related]
2. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. Wild J, Grusby MJ, Schirmbeck R, Reimann J. J Immunol; 1999 Aug 15; 163(4):1880-7. PubMed ID: 10438922 [Abstract] [Full Text] [Related]
3. Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Schirmbeck R, Böhm W, Reimann J. Intervirology; 1996 Aug 15; 39(1-2):111-9. PubMed ID: 8957677 [Abstract] [Full Text] [Related]
4. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Whalen RG, Leclerc C, Dériaud E, Schirmbeck R, Reimann J, Davis HL. Ann N Y Acad Sci; 1995 Nov 27; 772():64-76. PubMed ID: 8546414 [Abstract] [Full Text] [Related]
5. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes. Schirmbeck R, Stober D, El-Kholy S, Riedl P, Reimann J. J Immunol; 2002 Jun 15; 168(12):6253-62. PubMed ID: 12055239 [Abstract] [Full Text] [Related]
6. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses. Roh S, Lee YK, Ahn BY, Kim K, Moon A. Virus Res; 2001 Jan 15; 73(1):17-26. PubMed ID: 11163641 [Abstract] [Full Text] [Related]
7. DNA vector constructs that prime hepatitis B surface antigen-specific cytotoxic T lymphocyte and antibody responses in mice after intramuscular injection. Böhm W, Kuhröber A, Paier T, Mertens T, Reimann J, Schirmbeck R. J Immunol Methods; 1996 Jun 14; 193(1):29-40. PubMed ID: 8690928 [Abstract] [Full Text] [Related]
8. Enhancing the immunogenicity of exogenous hepatitis B surface antigen-based vaccines for MHC-I-restricted T cells. Schirmbeck R, Reimann J. Biol Chem; 1999 Mar 14; 380(3):285-91. PubMed ID: 10223330 [Abstract] [Full Text] [Related]
9. Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) S antigen in mice: implication for the pathogenesis of HBV-induced hepatitis. Schirmbeck R, Melber K, Mertens T, Reimann J. J Virol; 1994 Mar 14; 68(3):1418-25. PubMed ID: 8107205 [Abstract] [Full Text] [Related]
10. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Schirmbeck R, Reimann J. Intervirology; 2001 Mar 14; 44(2-3):115-23. PubMed ID: 11509872 [Abstract] [Full Text] [Related]
12. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen. Fomsgaard A, Nielsen HV, Bryder K, Nielsen C, Machuca R, Bruun L, Hansen J, Buus S. Scand J Immunol; 1998 Apr 14; 47(4):289-95. PubMed ID: 9600309 [Abstract] [Full Text] [Related]
14. Adjuvants that enhance priming of cytotoxic T cells to a Kb-restricted epitope processed from exogenous but not endogenous hepatitis B surface antigen. Schirmbeck R, Melber K, Reimann J. Int Immunol; 1999 Jul 14; 11(7):1093-102. PubMed ID: 10383942 [Abstract] [Full Text] [Related]
16. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. Böhm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, van Rooijen N, Barenholz Y, Reimann J. J Immunol; 1995 Oct 01; 155(7):3313-21. PubMed ID: 7561024 [Abstract] [Full Text] [Related]
17. Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination. Riedl P, El-Kholy S, Reimann J, Schirmbeck R. J Immunol; 2002 Aug 01; 169(3):1251-60. PubMed ID: 12133946 [Abstract] [Full Text] [Related]